Phase III
A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life sciences companies are trying to diagnose and cure.
Podcasting since 2024 • 13 episodes
Phase III
Latest Episodes
VAXXED: Deadly infection, with Imugene and ImmVirX
Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within this. And one says their work is not a vacc...
•
Season 3
•
Episode 2
•
23:13
VAXXED: From Gardasil to mRNA, with Dr Ian Frazer and Wilsons Advisory
Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.But today the science has moved on, to therapy vaccines. Vaccines that take immune cells...
•
Season 3
•
Episode 1
•
28:39
NUKED: Our nuclear future, with Novartis, Wilsons Advisory and Cyclotek
Drone-deliveries of radioactive medicines and diagnostics to Australia's far-flung towns. Radiopharmaceuticals matched with genetic information to tailor precisely the right dose and isotope to a person's cancer. Pan-cancer drugs that fix many ...
•
Season 2
•
Episode 6
•
34:16
NUKED: Patent puzzles, with FB Rice
The rule of thumb in biotech is that it costs around $1 billion to bring a new therapy from lab to market. Protecting that investment is the patent system. But what if part of your product is not made by your contract manufacturer, but by the p...
•
Season 2
•
Episode 5
•
25:20
NUKED: Australia the nuclear power, with entX and Cyclowest
Can Australia create a mine to lab to bedside production line for radiopharmaceutical medicine? It has the reactor, biotechs and the hospitals to do that last two, and even has a growing pool of expertise to run these. What it doesn...
•
Season 2
•
Episode 4
•
29:58